Antigenic variation in cancer metastasis: immune escape versus immune control (original) (raw)

• Fidler IJ, Gersten DM, Hart IR: The biology of cancer invasion and metastasis. Adv Cancer Res (28):149–250, 1978.
  Google Scholar
• Poste G, Fidler IJ: The pathogenesis of cancer metastasis. Nature London (283):139–146, 1980.
  Google Scholar
• Van Den Bossche H: The Host-Invader Interplay. Elsevier/North Holland, Amsterdam, 1980.
  Google Scholar
• Webster RG, Laver WG: Antigenic variation of influenza viruses. In: Kilburne ED (ed) The influenza viruses and influenza. Academic Press, New York, 1975, pp 269–314.
  Google Scholar
• Vickerman K: Antigenic variation in trypanosomes. Nature London (273):613–617, 1978.
  Google Scholar
• Hoeijmakers IHJ, Frasch ACC, Bernards A, Borst P, Cross GAM: Novel expression-linked copies of the genes for variant surface antigens in trypanosomes. Nature London (284):78–80, 1980.
  Google Scholar
• Prehm RT, Main JM: Immunity to methylcholanthrene-induced sarcomas. J Natl Cancer Inst (18):769–778, 1957.
  Google Scholar
• Wahl DV, Chapman WH, Hellström I, Hellström KE: Transplantation immunity to individually unique antigens of chemically induced bladder tumors in mice. Int J Cancer (14):114–121, 1974.
  Google Scholar
• Boon T, Kellerman O: Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line. Proc Natl Acad Sci (74):272, 1976.
  Google Scholar
• Boon T, Van Snick J, Van Pel A, Uyttenhove C, Marchand M: Immunogenic variants obtained by mutagenesis of mouse mastocytoma P 815. II. T lymphocyte-mediated cytolysis. J Exp Med (152):1184, 1980.
  Google Scholar
• Sugarbaker EV, Egan JE: Alterations of tumor specific transplantation antigens in metastases. Proc Am Assoc Cancer Res (296):74, 1971.
  Google Scholar
• Faraci RP: In vitro demonstration of altered antigenicity of metastases from a primary methylcholanthrene-induced sarcoma. Surgery (76):469–473, 1974.
  Google Scholar
• Fogel M, Segal S, Gorelik E, Feldman M: Specific cytotoxic lymphocytes against syngeneic tumors are generated in culture in the presence of syngeneic, but not xenogeneic, serum. Int J Cancer (22):329–334, 1978.
  Google Scholar
• Deichman GI, Kluchareva TE: Loss of transplantation antigen in primary Simian virus 40-induced tumors and their metastases. J Natl Cancer Inst (36):647–655, 1966.
  Google Scholar
• Kim U: Metastasizing mammary carcinomas in rats: induction and study of their immunogenicity. Science (167):72–74, 1970.
  Google Scholar
• Hewitt HB: The choice of animal tumors for experimental studies of cancer therapy. Adv Cancer Res (27):149–200, 1978.
  Google Scholar
• Parr I: Response of syngeneic murine lymphomata to immunotherapy in relation to the antigenicity of the tumor. Br J Cancer (26): 174–182, 1972.
  Google Scholar
• Schirrmacher V, Shantz G, Clauer K, Komitowski D, Zimmermann HP, Lohmann-Matthes ML: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. I. Tumor invasiveness in vitro and metastasis formation in vivo. Int J Cancer (23):233–244, 1979.
  Google Scholar
• Johnson RE, De Vita VT, Chabner BR, Chretien PB, Berard CD, Johnson SK: Patterns of involvement with malignant lymphoma and implications for treatment decision making. Br J Cancer (31), Suppl II:237–241, 1975.
  Google Scholar
• Nowell PC: The clonal evolution of tumor cell populations. Science (194):23–28, 1976.
  Google Scholar
• Schirrmacher V, Bosslet K: Tumor metastases and cellmediated immunity in a model system in DBA/2 mice. X. immunoselection of tumor variants differing in tumor antigen expression and metastatic capacity. Int J Cancer (25):781–788, 1980.
  Google Scholar
• Dzarlieva S, Schirrmacher V, Fusenig N: Cytogenetic changes during tumor progression towards invasion, metastasis and immune escape in the Eb/ESb model system (submitted for publication).
• Fogel M, Altevogt P, Schirrmacher V: Metastatic potential severely altered by changes in tumor cell adhesiveness (submitted for publication).
• Schwartz R, Schirrmacher V, Bosslet K, Mühlrad P: Glycoconjugates of murine tumor lines with different metastatic capacity. I. Differences in fucose utilization and in glycoprotein patterns (submitted for publication).
• Altevogt P, Kurnick JT, Kimura AK, Bosslet K, Schirrmacher V: Different expression of Lyt differentiation antigens and cell surface glycoproteins by a murine T lymphoma line and its high metastatic variant. Eur J Immunol (18):300–307, 1982.
  Google Scholar
• Schirrmacher V, Jacobs W: Tumor metastases and cellmediated immunity in a model system in DBA/2 mice. VIII. Expression and shedding of Fcγ receptors on metastatic tumor cell variants. J Supramol Struct (11):105–111, 1979.
  Google Scholar
• Barz D, Bosslet K, Schirrmacher V: Metastatic tumor cell variants with increased resistance to infection by Semliki-Forest-Virus. J Immunol (127):951–954, 1981.
  Google Scholar
• Davey GC, Currie GA, Alexander P: Spontaneous shedding and antibody induced modulation of histocompatibility antigens on murine lymphomata: correlation with metastatic spread. Br J Cancer (33):9–14, 1976.
  Google Scholar
• Vlodavsky I, Schirrmacher V, Ariav Y, Fuks Z: Lymphoma cell interaction with cultured vascular endothelial cells and with the subendothelial basal lamina: attachment, invasion and morphological appearance (submitted for publication).
• Davey GC, Currie GA, Alexander P: Immunity as the predominant factor determining metastasis by murine lymphomas. Br J Cancer (40):590–596, 1979.
  Google Scholar
• Schirrmacher V, Cheingsong-Popov R, Arnheiter H: Hepatocytetumor cell interaction in vitro. I. Conditions for rosette formation and inhibition by anti H-2 antibodies. J Exp Med (151):984–989, 1980.
  Google Scholar
• Lohmann-Matthes M-L, Schleich A, Shantz G, Schirrmacher V: Tumor metastasis and cell-mediated immunity in a model system in DBA/2 mice. VII. Interaction of metastasizing and nonmetastasizing tumors with normal tissue in vitro. J Natl Cancer Inst (64):1413–1425, 1980.
  Google Scholar
• Vlodavsky I, Ariav Y, Fuks Z, Altevogt P, Schirrmacher V: Lymphoma cell mediated degradation of sulfated proteoglycans and of fibronectin in the subendothelial basal lamina: relationship to tumor cell metastasis (submitted for publication).
• Waller CA, Schirrmacher V: Quantitative investigation of invasion in a murine paired lymphoma system (in preparation).
• Kerbel RS, Twiddy RR, Robertson MD: Induction of a tumor with greatly increased metastatic growth potential by the injection of cells from a low metastatic H-2 heterozygous tumour cell line into an H-2 incompatible parental strain. Int J Cancer (22):583, 1978.
  Google Scholar
• Dennis JW, Donaghue TP, Kerbel RS: Membrane-associated alterations detected in poorly tumorigenic lectinresistant variant sublines of a highly malignant and metastatic murine tumor. J Natl Cancer Inst (66):129–139, 1981.
  Google Scholar
• Kripke ML, Gruys E, Fidler IJ: Metastatic heterogeneity of cells from an ultraviolet light-induced murine fibrosarcoma of recent origin. Cancer Res (38):2962–2967, 1978.
  Google Scholar
• Nicolson GL, Winkelhake JL: Organ specificity of bloodborne metastasis determined by cell adhesion. Nature (255):230, 1975.
  Google Scholar
• Burger MM: The cell surface and metastasis. In: Biology of the cancer cell. Kugler, Amsterdam, 1980, pp 193–208.
  Google Scholar
• Kerbel RS, Dennis JW, Lagarde AE, Frost P: Tumor progression in metastasis: an experimental approach using lection resistant tumor variants. Cancer Metastasis Reviews (2):- , 1982.
• Fidler IJ, Gersten DM, Budmen MB: Characterization in vivo and in vitro of tumor cells selected for resistance to syngeneic lymphocyte-mediated cytotoxicity. Cancer Res (36):3160, 1976.
  Google Scholar
• Frost P, Kerbel RS: Immunoselection in vitro of a nonmetastatic variant from a highly metastatic tumor. Int J Cancer (27):381–385, 1981.
  Google Scholar
• Poste G: The influence of cell surface properties on the arrest of circulating melanoma cells. In: Hynes RO, Fox CF (eds) Tumor cell surfaces and malignancy. Progr Clin Biol Res (41):737–745, 1980.
• De Baetselier P, Gorelik E, Eshhar Z, Ron Y, Katzav S, Feldman M, Segal S: Hybridization between plasmacytoma cells and B lymphocytes confers metastatic properties on a non-metastatic tumor. J Natl Cancer Inst (67):1079–1087, 1981.
  Google Scholar
• Schirrmacher V: Immunogenetic studies on the resistance of mice against highly metastatic DBA/2 tumor cell variants. I. Effect of incompatabilities at H-2 or non-H-2 genes in normal and nude (nu/nu) mice. Invasion Metastasis (1):4–21, 1981.
  Google Scholar
• Schirrmacher V, Bosslet K, Altevogt P, Russman E, Beck L, Fogel M: Microenvironmental influences on tumor-host interactions studied with high and low metastatic tumor lines. Proc. VI. Meeting of EACR, Budapest. Kugler, Amsterdam (in press) 1982.
  Google Scholar
• Schirrmacher V, Hübsch D, Clauer K: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IX. Radioassay analysis of tumor cell spread from a local site to the blood and liver. In: Cancer Campaign, Grundmann E (ed) Metastatic tumor growth, Vol 4. Gustav Fischer Verlag, pp 147–158.
• Bosslet K, Schirrmacher V, Shantz G: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. VI. Similar specificity patterns of protective antitumor immunity in vivo and of cytolytic T cells in vitro. Int J Cancer (24):303–313, 1979.
  Google Scholar
• Eccles SA, Alexander P: Immunologically mediated restraint of latent tumor metastases. Nature (257):52–54. 1975.
  Google Scholar
• Wheelock EF, Weinhold KJ, Levich I: The tumor dormant state. Adv Cancer Res (34):107–140, 1981.
  Google Scholar
• Auerbach R, Morissey LW, Sidky Y: Regional differences in the incidence and growth of mouse tumors following intradermal and subcutaneous inoculation. Cancer Res (38):1739–1744, 1978.
  Google Scholar
• Afzelius LE, Elmage A, Nordgren H: Basal cell carcinoma in the head and neck. The importance of location and histological pictures studied with a new scoring system, predicting recurrences. Acta Pathol Microbiol Scand (88):5–9, 1980.
  Google Scholar
• Bellamy D, Hinsull SM: Influence of lodgement site on the proliferation of metastasis of Walker 256 carcinoma in the rat. Br J Cancer (37):81–85, 1978.
  Google Scholar
• Schirrmacher V: Commentary. Shifts in tumor cell phenotypes induced by signals from the microenvironment: relevance for the immunobiology of cancer metastasis. Immunobiology (157):89–98, 1980.
  Google Scholar
• Folkman J: Tumor angiogenesis and tumor immunity. In: Castro JE (ed) MTP Press, Immunological aspects of cancer Lancaster, England.
• Auerbach R, Kubai L, Sidky Y: Angiogenesis induction by tumors, embryonic tissues and lymphocytes. Cancer Res (36):3535–3440, 1976.
  Google Scholar
• Schirrmacher V, Waller CA: Quantitative determination of disseminated tumor cells by 3H-Thymidine incorporation in vitro and by agar colony formation. Cancer Res (42):660–666, 1982.
  Google Scholar
• Schirrmacher V, Bosslet K, Shantz G, Clauer K, Hübsch D: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. IV. Antigenic differences between the parental tumor line and its metastasizing variant. Int J Cancer (23):245–252, 1979.
  Google Scholar
• Bertschmann M, Schären B, Lüscher EF: Correlation of in vivo and in vitro immune reactions against intradermally developing P815 mastocytoma in the syngeneic mouse. Immunobiology (156):382–399, 1979.
  Google Scholar
• Hudack SS, McMaster PD: The lymphatic participation in human cutaneous phenomena. A study of the minute lymphatics of the living skin. J Exp Med (57):751, 1933.
  Google Scholar
• Fichtelius KE, Groth O, Liden S: The skin, a first level lymphoid organ? Int Arch Allergy Appl Immunol (37): 607–620, 1970.
  Google Scholar
• Chassoux D, McLennan ICM, Munzo TR: Competition for cytotoxic immune capacity against a syngeneic tumour distributed at two sites. Int J Cancer (19):796, 1977.
  Google Scholar
• Shantz G, Schirrmacher V: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. III. Induction and specificity of syngeneic cytotoxic T cells. In: Quastel MR (ed) Cell biology and immunology of leukocyte function. Academic Press, New York, 1979, pp 725–736.
  Google Scholar
• Glaser M, Herberman RB: Secondary cell-mediated cytotoxic response to challenge of rats with syngeneic Gross-virus induced lymphomas. J Natl Cancer Inst (56):1211, 1976.
  Google Scholar
• Pilarski LM: Antigen-specific helper T cells are essential for cytotoxic T cell responses to metabolically inactivated stimulator cells. Eur J Immunol (9):454–460, 1979.
  Google Scholar
• Wagner H, Hardt C, Heeg K, Pfizenmaier K, Solbach W, Bartlett R, Stockinger H, Röllinghoff M: T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell derived helper factor (interleukin 2) as a probe to analyse CTL. responsiveness and thymic maturation of CTL progenitors. Immunol (51):215–256, 1980.
  Google Scholar
• Warren HS, Woolnough JA, Denarv CP, Lafferty KJ: Cytotoxic T cell responses to a syngeneic tumor: conditions for primary activation in vitro and biological activity in vivo. In: Müller-Ruchholtz W, Müller-Hermelink HK (eds) Advances in experimental medicine and biology, New York-London, pp 757–761. Vol 14. Plenum Press.
• Mills GB, Paetkau V: Generation of cytotoxic lymphocytes to syngeneic tumor by using co-stimulator (interleukin 2). J. Immunol (125):1897–1903, 1980.
  Google Scholar
• Burton RC, Plate JMD: Helper factor(s) augment in vitro induction of tumor-specific immunity. Cell Immunol (58):225–237, 1981.
  Google Scholar
• Kim U, Baumler A, Carruthers C, Bielat K: Immunological escape mechanism in spontaneously metastasizing mammary tumors. Proc Natl Acad Sci (72): 1012–1016, 1975.
  Google Scholar
• Hopkins N, Beamer P, DeLeo AB, Law LW: High-frequency cotransfer of the transformed phenotype and a tumor specific transplantation antigen by DNA from the 3-methylcholanthreneinduced Meth. A sarcoma of BALB/c mice. Proc Natl Acad Sci (78):7555–7559, 1981.
  Google Scholar
• Pratcheva D, DeLeo AB, Ruddle F, Old LJ: Chromosome assignment of the tumor-specific antigen of a 3-methyl-cholanthreneinduced mouse sarcoma. J Exp Med (154):964–977, 1981.
  Google Scholar
• Law LW, Rogers MJ, Appella E: Tumor antigens on neoplasms induced by chemical carcinogens and by DNA- and RNA-containing viruses: properties of the solubilized antigens. Adv Cancer Res (32):201–235, 1980.
  Google Scholar
• Schirrmacher V, Bosslet K: Clonal analysis of expression of tumor-associated transplantation antigens and of metastatic capacity. Cancer Immunol Immunother (13):62–68, 1982.
  Google Scholar
• Schirrmacher V, Altevogt P, Bosslet K: Spontaneous phenotypic shifts from low to high metastatic capacity. Proc NATO Conference ‘Biochemical and Biological Markers of Neoplastic Transformation,’ 1981.
• Bosslet K, Ruffmann R, Altevogt P, Schirrmacher V: A rapid method for the isolation of metastasizing tumor cells from internal organs with the help of isopycnic density gradient centrifugation in Percoll. Br J Cancer (44):356–362, 1981.
  Google Scholar
• Bosslet K, Schirrmacher V: Escape of metastasizing clonal tumor cell variants from tumor-specific cytolytic T lymphocytes. J Exp Med (154):557–562, 1981.
  Google Scholar
• Bosslet K, Schirrmacher V: High-frequency generation of new immunoresistant tumor variants during metastasis of a cloned murine tumor line (ESb). Int J Cancer (29):195–202, 1982.
  Google Scholar
• Biddison WE, Palmer JC: Development of tumor cell resistance to syngeneic cell-mediated cytotoxicity during growth of ascitic mastocytoma P815Y. Proc Natl Acad Sci (74):329–333, 1977.
  Google Scholar
• Weinhold KJ, Miller DA, Wheelock EF: The tumor dormant state. Comparison of L5178Y cells used to establish dormancy with those that emerge after its termination. J Exp Med (149):745–757, 1979.
  Google Scholar
• Fidler IJ, Kripke ML: Metastasis results from pre-existing variant cells within a malignant tumor. Science (197):893, 1977.
  Google Scholar
• Cairns I: The origin of human cancers. Nature (289):353–357, 1981.
  Google Scholar
• Nevers P, Saedler H: Translocatable genetic elements as agents of gene instability and chromosomal rearrangements. Nature (268):109–115, 1977.
  Google Scholar
• Strathern IN, Herskowitz K: Asymmetry and directionality in production of new cell types during clonal growth: the switching pattern of homothallic yeast. Cell (17):371–381, 1979.
  Google Scholar
• Klein G: The role of gene dosage and genetic transpositions in carcinogenesis. Nature (294):313–318, 1981.
  Google Scholar
• Pays E, Van Meirvenne N, Le Ray D, Steward M: Gene duplication and transposition linked to antigenic variation in Trypanosoma brucei, Proc Natl Acad Sci (78):2673–2677, 1981.
  Google Scholar
• Dennis JW, Donaghue TP, Kerbel RS: An examination of tumor antigen loss in spontaneous metastases. Invasion Metastasis (2):111–125, 1981.
  Google Scholar
• Urban IL, Burton RC, Holland JM, Kripke ML, Schreiber H: Mechanisms of syngeneic tumor rejection. Susceptibility of host-selected progressor variants to various immunological effector cells. J Exp Med (155):557–573, 1982.
  Google Scholar
• Boyse EA, Stockert E, Old LJ: Modification of the antigenic structure of the cell membrane by thymusleukemia (TL) antibody. Proc Natl Acad Sci. (58):954, 1967.
  Google Scholar
• Hilgers J, Sonnenberg A, Nusse R: Antigenic modulation of mammary tumor virus envelope antigen on GR thymic lymphoma cells in relation to expression of H-2, TL cell surface antigens and Thy 1. Br J Cancer (42):542, 1980.
  Google Scholar
• Stackpole CW: Modulation of thymus-leukemia antigens on mouse leukemia cells induced by IgG, but not IgM, antibody. J Natl Cancer Inst (64):917, 1980.
  Google Scholar
• Hellström KE, Hellström I: Lymphocyte-mediated cytotoxicity and blocking serum activity to tumor antigens. Adv Immunol (18):209, 1974.
  Google Scholar
• Broder S, Muul L, Waldmann TA: Suppressor cells in neoplastic disease. J Natl Cancer Inst (61):5–11, 1978.
  Google Scholar
• Naor D: Suppressor cells: permitters and promoters of malignancy? Adv Cancer Res (29):45–125, 1979.
  Google Scholar
• Berendt MI, North NJ: T cell mediated suppression of antitumor immunity. An explanation for progressive growth of an immunogenic tumor. J Exp Med (159):69–80, 1980.
  Google Scholar
• Fidler IJ, Gersten DM, Kripke ML: Influence of immune status on the metastases of three murine fibrosarcomas of different immunogenicities. Cancer Res (39):3816–3821, 1979.
  Google Scholar
• Lindenmann J, Klein PA: Viral oncolysis: increased immunogenicity of host cell antigen associated with influenza virus. J Exp Med (126):93–108, 1967.
  Google Scholar
• Kobayashi H: Viral xenogenization of intact tumor cells. Adv Cancer Res (30):279–299, 1979.
  Google Scholar
• Austin FC, Boone CW: Virus augmentation of the antigenicity of tumor cell extracts. Adv Cancer Res (30):301–345, 1979.
  Google Scholar
• Dennert G, Weiss S, Warner IF: T cells may express multiple activities. Specific allohelp, cytolysis and delayed-type hypersensitivity are expressed by a cloned T cell line. Proc Natl Acad Sci (79):695, 1982.
  Google Scholar
• Burton RC, Warner NL: In vitro induction of tumor specific immunity. IV. Specific adoptive immunotherapy with cytotoxic T cells induced in vitro to plasmacytoma antigens. Cancer Immunol Immunother (2):91–99, 1977.
  Google Scholar
• Kedar E, Schwartzbach M, Hefetz S, Raanan Z: In vitro induction of cell-mediated immunity to murine leukemia cells. V. Adoptive immunotherapy of leukemia in mice with lymphocytes sensitized in vitro to leukemia cells. Cancer Immunol Immunother (4):151–159, 1978.
  Google Scholar
• Cheever MA, Greenberg PD, Feder A: Adoptive therapy of established syngeneic leukemia by cells primarily sensitized in vitro. Cancer Res (41):2658–2663, 1981.
  Google Scholar
• Fernandez-Cruz E, Woda BA, Feldman JD: Elimination of syngeneic sarcomas in rats by a subset of T lymphocytes. J Exp Med (152):823–841, 1980.
  Google Scholar
• Shu S, Steerenberg PA, Hunter JT, Evans CH, Rapp HJ: Adoptive immunity to the guinea pig line 10 hepatoma and the nature of in vitro lymphoid-tumor cell interactions. Cancer Res (41):3499–3506, 1981.
  Google Scholar
• Wiltrout RH, Frost P, Morrison M, Kerbel RS: Immune-mediated arrest and reversal of established visceral metastases in athymic mice. Cancer Res (39):4034–4041, 1979.
  Google Scholar
• Yam LT, Li CY, Crosby WH: Cytochemical identification of monocytes and granulocytes. Am J Clin Pathol (55):283, 1971.
  Google Scholar
• Schirrmacher V, Landolfo S, Zawatzky R, Kirchner H: Immunogenetic studies on the resistance of mice against highly metastatic DBA/2 tumor cell variants. II. Influence of minor histocompatibility antigens on tumor resistance, interferon induction and cytotoxic response. Invasion Metastasis (1):175–194, 1981.
  Google Scholar
• Lake P, Douglas TC: Recognition and genetic control of helper determinants of cell surface antigen Thy 1. Nature (273):220, 1978.
  Google Scholar
• Lake P, Mitchison NA: Regulatory mechanisms in the immune response to cell surface antigens. Cold Spring Harbor Symp Quant Biol (41):589–595, 1977.
  Google Scholar
• Schirrmacher V: Tumor metastases and cell-mediated immunity in a model system in DBA/2 mice. V. Transfer of protective immunity with H-2 identical immune T cells from B10.D2 mice. Int J Cancer (24):80–86, 1979.
  Google Scholar
• Berenson IR, Einstein AB, Fefer A: Syngeneic adoptive immunotherapy and chemoimmunotherapy of a Friend leukemia: requirements for T cells. J Immunol (115):234–238, 1975.
  Google Scholar
• Cheever MA, Greenberg PD, Fefer A: Tumor neutralization, immunotherapy and chemoimmunotherapy of a Friend leukemia with cells secondarily sensitized in vitro. II. Comparison of cells cultured with and without tumor to noncultured immune cells. J Immunol (121):2220–2227, 1978.
  Google Scholar
• Glaser M, Lavrin DH, Herbermann RB: In vivo protection against syngeneic Gross virus-induced lymphoma in rats: comparison with in vitro studies of cell-mediated immunity. J Immunol (116):1507–1511, 1976.
  Google Scholar
• Mihich E: Combined effects of chemotherapy and immunity against leukemia L 1210 in DBA/2 mice. Cancer Res (29):848–854, 1969.
  Google Scholar
• Cifone M, Fidler IJ: Increasing metastatic potential is associated with increasing genetic instability of clones isolated from murine neoplasms. Proc Natl Acad Sci (78):6949–6952, 1981.
  Google Scholar
• Fischer MS, Cifone MA: Enhanced metastatic potential of murine fibrosarcomas treated in vitro with ultraviolet radiation. Cancer Res (41):3018–3023, 1981.
  Google Scholar